MANINI, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 5.613
NA - Nord America 5.209
AS - Asia 2.609
SA - Sud America 525
Continente sconosciuto - Info sul continente non disponibili 169
AF - Africa 119
OC - Oceania 9
Totale 14.253
Nazione #
US - Stati Uniti d'America 5.102
GB - Regno Unito 1.756
RU - Federazione Russa 993
IT - Italia 968
CN - Cina 859
SG - Singapore 775
IE - Irlanda 583
BR - Brasile 437
VN - Vietnam 320
SE - Svezia 267
FR - Francia 247
UA - Ucraina 237
DE - Germania 227
HK - Hong Kong 207
FI - Finlandia 145
KR - Corea 118
IN - India 86
BD - Bangladesh 62
CA - Canada 58
AR - Argentina 49
ZA - Sudafrica 43
ES - Italia 34
IQ - Iraq 29
PL - Polonia 28
AT - Austria 27
CI - Costa d'Avorio 27
MX - Messico 27
NL - Olanda 21
JP - Giappone 19
ID - Indonesia 18
BE - Belgio 16
TR - Turchia 16
NG - Nigeria 15
PK - Pakistan 13
MA - Marocco 12
LT - Lituania 11
CZ - Repubblica Ceca 10
EC - Ecuador 9
UZ - Uzbekistan 9
CO - Colombia 8
KE - Kenya 8
NP - Nepal 8
AU - Australia 7
CH - Svizzera 7
JM - Giamaica 7
OM - Oman 7
PH - Filippine 7
SA - Arabia Saudita 7
IL - Israele 6
PT - Portogallo 6
AZ - Azerbaigian 5
CL - Cile 5
IR - Iran 5
MY - Malesia 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CR - Costa Rica 4
GR - Grecia 4
JO - Giordania 4
PY - Paraguay 4
VE - Venezuela 4
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
HU - Ungheria 3
KH - Cambogia 3
KZ - Kazakistan 3
LV - Lettonia 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BY - Bielorussia 2
ET - Etiopia 2
GT - Guatemala 2
KW - Kuwait 2
NI - Nicaragua 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
LB - Libano 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
Totale 14.086
Città #
Southend 1.612
Dublin 582
Dallas 577
Fairfield 451
Singapore 393
Ashburn 363
Santa Clara 315
Chandler 289
Moscow 245
Woodbridge 231
Milan 222
Beijing 220
Houston 209
Siena 204
San Jose 203
Wilmington 200
Hong Kong 197
Jacksonville 195
Seattle 194
Cambridge 168
Hefei 146
Council Bluffs 123
Seoul 117
Ann Arbor 109
The Dalles 93
Princeton 89
Ho Chi Minh City 87
Los Angeles 82
Dong Ket 77
Rome 75
Helsinki 70
Nanjing 70
Munich 66
New York 64
Lauterbourg 62
Hanoi 53
São Paulo 40
San Mateo 39
Buffalo 37
Florence 36
Boardman 35
Johannesburg 35
Lappeenranta 34
San Diego 29
Toronto 28
Abidjan 27
Nanchang 25
Málaga 23
Redondo Beach 23
Bengaluru 22
Columbus 22
Orem 22
Shenyang 21
Frankfurt am Main 20
Mumbai 20
Warsaw 20
Phoenix 18
Shanghai 17
Tianjin 17
Tokyo 17
Vienna 17
Figino 16
Kunming 16
London 16
Rio de Janeiro 16
Baghdad 15
Brussels 15
Chicago 15
Da Nang 15
Abuja 14
Denver 14
Hebei 14
Nuremberg 14
Brasília 13
Brooklyn 13
Manchester 13
Norwalk 13
Dearborn 12
Montreal 12
Chennai 11
Hangzhou 11
San Francisco 11
Turin 11
Turku 11
Belo Horizonte 10
Naples 10
Stockholm 10
Amsterdam 9
Atlanta 9
Boston 9
Fremont 9
Guangzhou 9
Jinan 9
Poplar 9
Curitiba 8
Dhaka 8
Taizhou 8
Tashkent 8
Barnet 7
Brescia 7
Totale 9.547
Nome #
"OKKIO alla salute 2014" results from the Tuscan sample 695
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 547
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 512
Egg-Independent Influenza Vaccines and Vaccine Candidates 332
Constant expression of hexose-6-phosphate dehydrogenase during differentiation of human adipose-derived mesenchymal stem cells 306
Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2 298
Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression 292
A method for detection of neuraminidase antibody in serum 291
Flucelvax (Optaflu) for seasonal influenza 282
Challenges in the development of egg-independent vaccines for influenza 279
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 261
Immunogenicity and safety of the new inactivated quadrivalent influenza vaccine vaxigrip tetra: Preliminary results in children ≥6 months and older adults 261
Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season 257
Moderate vaccine effectiveness against severe acute respiratory infection caused by a(H1N1)pdm09 influenza virus and no effectiveness against a(H3N2) influenza virus in the 2018/2019 season in Italy 251
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season 248
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 243
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice 240
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 235
Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development 233
RT-PCR multiplex per l’identificazione simultanea di influenza virus A/H1N1 A/H3N2 e B e Virus Respiratorio Sinciziale di tipo A e B 230
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells 219
CORRELATES OF PROTECTION AND HOST-RELATED MODIFIERS OF THE IMMUNOGENICITY OF INFLUENZA VACCINES: EVIDENCE MAPS AND EVIDENCE GAPS 218
Mapping host-related correlates of influenza vaccine-induced immune response: An umbrella review of the available systematic reviews and meta-analyses 205
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? 200
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 198
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 195
Safety, tolerability and immunogenicity of a mammalian cell culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial 192
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy 191
Pre-emptive vaccination against pandemic influenza virus 189
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 189
Hepatitis A infection in central Tuscany in children and youths 186
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 178
Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap? 177
Trend of accesses to the ED of Teaching Hospital of Tuscany for bronchiolitis 2018-2023: new emergency 176
Hepatitis A seroprevalence in Tuscany, Italy 176
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 173
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany 166
Evaluation of maternal perception of children's weight and body mass index in tuscany, Italy 164
Trend of Correlations between Psychological Symptoms and Socioeconomic Inequalities among Italian Adolescents: Cross-Sectional Study from 2006 to 2018 in Tuscany Region 163
Epidemiology and prevention of Human Papillomavirus 163
Effetti dell’ozono sui microrganismi 162
La vaccinazione influenzale e l’eterovarianza dei ceppi circolanti: uno studio comparativo 160
Epidemiological and virological surveillance of Severe Acute Respiratory Infections in the 2019/2020 season in Siena, Tuscany, Italy 160
There is a correlation between nutritional status, Self-Rated Health and Life Satisfaction? Evidence from 2018 Health Behaviour in School-aged Children cross sectional study in a sample of Italian adolescents living in Tuscany Region 157
Surveillance of Influenza and Other Airborne Transmission Viruses during the 2021/2022 Season in Hospitalized Subjects in Tuscany, Italy 156
Use of pseudotyped particles expressing influenza A/Viet Nam/1194/2004 haemagglutinin in immunological assays 156
Trend della prevalenza di sovrappeso e obesità nei bambini toscani in età scolare dal 2002 al 2016 [Trends of overweight and obesity prevalence among schoolchildren in Tuscany Region (Central Italy), period 2002-2016] 155
Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials 153
Validation of Single Radial Haemolysis assay for detection of H5 influenza antibodies 152
Lower frequency of SARS-CoV-2-associated severe respiratory infections among adults vaccinated against the 2021/22 season influenza 148
Sieroepidemiologia della varicella in donne in età fertile 146
Real time PCR per la diagnosi simultanea di virus influenzali di tipo A 142
How Family Structure Can Influence Adolescents’ Eating Habits: An Italian Health Behaviour in School-Aged Children (HBSC) 2022 Sample 141
Valutazione dell’immunogenicità di due vaccini antinfluenzali a confronto 136
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 135
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm) 134
Sicurezza e risposta immunitaria di un vaccino antinfluenzale prodotto in cellule MDCK in Soggetti Adulti ed Anziani Sani 129
Risultati e prospettive del Piano Regionale per l'Eliminazione del Morbillo e della Rosolia Congenita in Toscana. 126
Usability of SRH assay to titration H5 antigen 126
Sieroprevalenza dell'epatite A in Toscana in bambini e giovani adulti 126
Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection 124
Valutazione microbiologica dell’aria di uno stabulario 124
Sorveglianza virologica della nuova variante del virus influenzale A/H1N1 nell’Area Vasta Toscana sud 118
null 116
Seroepidemiology of Influenza A/H5N1 Virus in the Italian Population Since from 1992 until to 2007 112
Surveillance of Severe Acute Respiratory Infection and Influenza Vaccine Effectiveness among Hospitalized Italian Adults, 2021/22 Season 111
SARS-CoV-2, influenza, HRSV and other respiratory pathogens during the post-COVID-19 era: Epidemic circulation in Italy in the 2023/2024 season 110
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 109
Seroepidemiology of influenza A/H5N1 virus in the Italian population from 1992 to 2007 107
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 104
Relative effectiveness of the adjuvanted vs non-adjuvanted seasonal influenza vaccines against severe laboratory-confirmed influenza among hospitalized Italian older adults 75
Health Profiles in Developmental Age: An Analysis of the Eating Habits and Lifestyles of a Sample of Italian Children 67
Influenza D Virus: A Potential Threat for Humans? 65
Totale 14.253
Categoria #
all - tutte 43.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022727 0 113 81 83 25 15 29 44 63 52 75 147
2022/20231.059 63 87 145 148 93 212 39 87 95 30 33 27
2023/2024893 36 28 44 37 51 203 327 26 8 34 29 70
2024/20251.984 50 111 221 101 277 117 85 80 163 69 196 514
2025/20264.911 380 587 529 639 853 196 523 149 180 302 164 409
2026/2027245 208 37 0 0 0 0 0 0 0 0 0 0
Totale 14.253